Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | EGFR | P00533 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | FYN | P06241 | 1/20 | 0.52 |
| ▸ | MMP2 | P08253 | 1/20 | 0.52 |
| ▸ | MMP9 | P14780 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | MMP8 | P22894 | 1/20 | 0.52 |
| ▸ | CA6 | P23280 | 1/20 | 0.52 |
| ▸ | CDK2 | P24941 | 1/20 | 0.52 |
| ▸ | MMP12 | P39900 | 1/20 | 0.52 |
| ▸ | RECQL | P46063 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | ADAMTS5 | Q9UNA0 | 1/20 | 0.52 |
| ▸ | IAPP | P10997 | 4/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL622788 | 0.98 | ADAMTS4 (0.50) | ADAMTS4ALDH1A1EGFRCA1CA2 | |
| Hydrochloric Acid SCHEMBL1998632 | 0.98 | ADAMTS4 (0.50) | ADAMTS4ALDH1A1EGFRCA1CA2 | |
| SCHEMBL20182944 | 0.87 | GABRA1 (0.55) | ADAMTS4ALDH1A1EGFRCA1CA2 | |
| SCHEMBL68660 | 0.81 | TAAR1 (0.68) | ADAMTS4ALDH1A1EGFRCA1CA2 | |
| SCHEMBL29531687 | 0.81 | TAAR1 (0.68) | ADAMTS4ALDH1A1EGFRCA1CA2 | |
| Hydrochloric Acid SCHEMBL10880379 | 0.79 | TAAR1 (0.65) | ADAMTS4ALDH1A1EGFRCA1CA2 | |
| SCHEMBL2788678 | 0.79 | HSPA5 (0.62) | ADAMTS4ALDH1A1EGFRCA1CA2 | |
| 2-(Aminomethyl)Phenol SCHEMBL110156 | 0.79 | — | — | |
| SCHEMBL24349403 | 0.78 | GABRA1 (0.46) | LMNATAAR1PNMTGABRA1GABRB2 | |
| SCHEMBL2019654 | 0.78 | MMP2 (0.43) | ALDH1A1MMP2HPGDALOX15HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119189451-A | Strong waterproof high-moisture-permeability jacket fabric and preparation method thereof | 无锡市世纪风服饰有限公司 | 2024-12-27 | — | — | CN | claimed |
| CN-117988119-A | Carbon fiber surface sizing agent and epoxy resin prepreg prepared from same | 常州融信复合材料有限公司 | 2024-05-07 | — | — | CN | claimed |
| CN-110368906-B | Preparation method of adsorbent for adsorbing uranium | 中核第四研究设计工程有限公司 | 2022-08-19 | — | — | CN | claimed |
| US-9844610-B2 | Method for preparing in situ-formed hydrogel using enzyme-immobilized support, and biomedical use thereof | AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) | 2017-12-19 | — | — | US | claimed |
| US-20150250890-A1 | METHOD FOR PREPARING IN SITU-FORMED HYDROGEL USING ENZYME-IMMOBILIZED SUPPORT, AND BIOMEDICAL USE THEREOF | AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) | 2015-09-10 | — | — | US | claimed |
| EP-0752872-A4 | NADH OXIDASE AS A TARGET IN DIAGNOSIS AND THERAPY | MORRE D JAMES (US) | 2005-01-19 | — | — | EP | claimed |
| EP-0752872-A1 | NADH OXIDASE AS A TARGET IN DIAGNOSIS AND THERAPY | Portola Sciences, Inc. (US) | 1997-01-15 | — | — | EP | claimed |
| US-5569673-A | ANTICARCINOGENIC AGENTS | PURDUE RESEARCH FOUNDATION (US) | 1996-10-29 | — | — | US | claimed |
| WO-1995026743-A1 | NADH OXIDASE AS A TARGET IN DIAGNOSIS AND THERAPY | PORTOLA SCIENCES, INC. (US) | 1995-10-12 | — | — | WO | claimed |
| CN-119189451-A | Strong waterproof high-moisture-permeability jacket fabric and preparation method thereof | 无锡市世纪风服饰有限公司 | 2024-12-27 | — | — | CN | disclosed |
| CN-117988119-A | Carbon fiber surface sizing agent and epoxy resin prepreg prepared from same | 常州融信复合材料有限公司 | 2024-05-07 | — | — | CN | disclosed |
| CN-117988119-A | Carbon fiber surface sizing agent and epoxy resin prepreg prepared from same | 常州融信复合材料有限公司 | 2024-05-07 | — | — | CN | disclosed |
| EP-3229771-B1 | 6-ARYL-9-GLYCOSYLPURINES AND USE THEREOF | UNIV PALACKEHO (CZ) | 2024-04-03 | — | — | EP | disclosed |
| US-20230063230-A1 | NURR1 RECEPTOR MODULATORS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-03-02 | — | — | US | disclosed |
| US-20040191672-A1 | Resist composition | MITSUBISHI GAS CHEMICAL CO., LTD. (JP) | 2004-09-30 | — | — | US | disclosed |
| EP-1443362-A2 | Resist composition | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2004-08-04 | — | — | EP | disclosed |
| EP-0752872-A1 | NADH OXIDASE AS A TARGET IN DIAGNOSIS AND THERAPY | Portola Sciences, Inc. (US) | 1997-01-15 | — | — | EP | disclosed |
| US-5569673-A | ANTICARCINOGENIC AGENTS | PURDUE RESEARCH FOUNDATION (US) | 1996-10-29 | — | — | US | disclosed |
| US-5569673-A | ANTICARCINOGENIC AGENTS | PURDUE RESEARCH FOUNDATION (US) | 1996-10-29 | — | — | US | disclosed |
| WO-1995026743-A1 | NADH OXIDASE AS A TARGET IN DIAGNOSIS AND THERAPY | PORTOLA SCIENCES, INC. (US) | 1995-10-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230063230-A1 | NURR1 RECEPTOR MODULATORS | NR2E3, NR4A2, NR0B1 | ADAMTS4 4614/4885ALDH1A1 1591/4885EGFR 2030/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.